Abstract
Iron oxide nanoparticles (ION) have attracted much attention because of their particular physico-chemical properties, including superparamagnetism. These features make them suitable for many purposes and several interesting biomedical applications, such as to increase contrast in magnetic resonance imaging (MRI), as drug delivery systems and as hyperthermia agents. However, they have also shown to be easily accumulated in diverse tissues and induce toxicity at different levels. This chapter reviews the different cellular and molecular effects induced by ION reported from in vitro studies with human and non-human cell lines. Those effects are mainly dependent on ION type and concentration, time of exposure, presence and nature of coating, and cell type evaluated. They include decreases in viability, plasmatic membrane disruption, oxidative damage, mitochondrial alterations, cell cycle impairments, cytoskeleton disruption, cell death, and alterations in cell motility, and in cell integrity. Despite these negative effects, the numerous advantages of ION together with their promising applications in biomedicine, make it necessary to clearly define their toxicity in order to discard potential health risks and to reach optimal benefits of their use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dissanayake NM, Current KM, Obare SO (2015) Mutagenic effects of Iron oxide nanoparticles on biological cells. Int J Mol Sci 16:23482–23516
Revia RA, Zhang M (2016) Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater Today 19:157–168
Lin MM, Kim DK, El Haj AJ et al (2008) Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications. IEEE Trans Nanobioscience 7:298–305
Rosen JE, Chan L, Shieh D-B et al (2012) Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine 8:275–290
Anselmo AC, Mitragotri S (2016) Nanoparticles in the clinic. Bioeng Transl Med 1:10–29
Ittrich H, Peldschus K, Raabe N et al (2013) Superparamagnetic iron oxide nanoparticles in biomedicine: applications and developments in diagnostics and therapy. RöFo Fortschritte Auf Dem Gebiete Der Röntgenstrahlen Und Der Nukl 185:1149–1166
Kim JE, Shin JY, Cho MH (2012) Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch Toxicol 86:685–700
Mok H, Zhang M (2013) Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin Drug Deliv 10:73–87
Wahajuddin AS (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 7:3445–3471
Laurent S, Dutz S, Häfeli UO et al (2011) Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interf Sci 166:8–23
Wang YXJ, Xuan S, Port M et al (2013) Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research. Curr Pharm Des 19:6575–6593
Torres-Lugo M, Rinaldi C (2013) Thermal potentiation of chemotherapy by magnetic nanoparticles. Nanomedicine (London) 8:1689–1707
Grüttner C, Müller K, Teller J et al (2013) Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications. Int J Hyperth 29:777–789
Estelrich J, Escribano E, Queralt J et al (2015) Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci 16:8070–8101
Zhu XM, Wang YXJ, Cham-Fai Leung K et al (2012) Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines. Int J Nanomedicine 7:953–964
Mahdavi M, Bin AM, Haron MJ et al (2013) Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications. Molecules 18:7533–7548
Mahmoudi M, Simchi A, Milani AS et al (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci 336:510–518
Wu W, He Q, Jiang C (2008) Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett 3:397–415
Bjørnerud A, Johansson L (2004) The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. NMR Biomed 17:465–477
Wang YXJ, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319–2331
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–3402
Santhosh PB, Ulrih NP (2013) Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. Cancer Lett 336:8–17
Petters C, Bulcke F, Thiel K et al (2014) Uptake of fluorescent iron oxide nanoparticles by oligodendroglial OLN-93 cells. Neurochem Res 39:372–383
Yu M, Huang S, Yu KJ et al (2012) Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int J Mol Sci 13:5554–5570
Alwi R, Telenkov S, Mandelis A et al (2012) Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics. Biomed Opt Express 3:2500–2509
Tong L, Zhao M, Zhu S et al (2011) Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer. Front Med 5:379–387
Xia T, Kovochich M, Liong M et al (2009) Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3:3273–3286
Figuerola A, Di Corato R, Manna L et al (2010) From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 62:126–143
Jin R, Lin B, Li D et al (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27
Bertorelle F, Wilhelm C, Roger J et al (2006) Fluorescence-modified superparamagnetic nanoparticles: intracellular uptake and use in cellular imaging. Langmuir ACS J Surf Colloids 22:5385–5391
Ge Y, Zhang Y, He S et al (2009) Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging. Nanoscale Res Lett 4:287–295
Petters C, Irrsack E, Koch M et al (2014) Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res 39:1648–1660
Yan F, Wang Y, He S et al (2013) Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood-brain barrier. J Mater Sci Mater Med 24:2371–2379
Agemy L, Friedmann-Morvinski D, Kotamraju VR et al (2011) Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A 108:17450–17455
Kumar M, Singh G, Arora V et al (2012) Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int J Nanomedicine 7:3503–3516
Hassan EE, Gallo JM (1993) Targeting anticancer drugs to the brain. I: enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J Drug Target 1:7–14
Jenkins SI, Pickard MR, Granger N et al (2011) Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies. ACS Nano 5:6527–6538
Choi JW, Park JW, Na Y et al (2015) Using a magnetic field to redirect an oncolytic adenovirus complexed with iron oxide augments gene therapy efficacy. Biomaterials 65:163–174
Krötz F, de Wit C, Sohn HY et al (2003) Magnetofection – a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther J Am Soc Gene Ther 7:700–710
Kumar M, Yigit M, Dai G et al (2010) Image-guided breast tumor therapy using a small interfering RNA nanodrug. Cancer Res 70:7553–7561
Singh N, Jenkins GJS, Asadi R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1:5358
Kumari M, Rajak S, Singh SP et al (2012) Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats. Drug Chem Toxicol 36:1–10
Radu M, Din I, Hermenean A et al (2015) Exposure to iron oxide nanoparticles coated with phospholipid-based polymeric micelles induces biochemical and histopathological pulmonary changes in mice. Int J Mol Sci 16:29417–29435
Sadeghi L, Yousefi Babadi V, Espanani HR (2015) Toxic effects of the Fe2O3 nanoparticles on the liver and lung tissue. Bratisl Lek Listy 116:373–378
Hussain SM, Hess KL, Gearhart JM et al (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–983
Jeng H, Swanson J (2006) Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Heal Part A Toxic/Hazard Subst Environ Eng 4112:2699–2711
Karlsson HL, Gustafsson J, Cronholm P et al (2009) Size-dependent toxicity of metal oxide particles-A comparison between nano- and micrometer size. Toxicol Lett 188:112–118
Karlsson HL, Cronholm P, Gustafsson J et al (2008) Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 21:1726–1732
Kunzmann A, Andersson B, Vogt C et al (2011) Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 253:81–93
Cromer Berman SM, Kshitiz CJ, Wang CJ et al (2013) Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med 69:255–262
Wu X, Tan Y, Mao H et al (2010) Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine 5:385–399
Patil US, Adireddy S, Jaiswal A et al (2015) In vitro/in vivo toxicity evaluation and quantification of iron oxide nanoparticles. Int J Mol Sci 16:24417–24450
Liu Y, Xia Q, Liu Y et al (2014) Genotoxicity assessment of magnetic iron oxide nanoparticles with different particle sizes and surface coatings. Nanotechnology 25:425101
Soenen SJH, Himmelreich U, Nuytten N et al (2011) Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 32:195–205
Rivet CJ, Yuan Y, Borca-Tasciuc DA et al (2012) Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 25:153–161
Magdolenova Z, Drlickova M, Henjum K et al (2013) Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology 5390:1–13
Sun Z, Yathindranath WM et al (2013) Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models. Int J Nanomedicine 8:961–970
Couto D, Freitas M, Vilas-Boas V et al (2014) Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils. Toxicol Lett 225:57–65
Schütz CA, Staedler D, Crosbie-Staunton K et al (2014) Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles. Int J Nanomedicine 9:3481–3498
Hong SC, Lee JH, Lee J et al (2011) Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomedicine 6:3219–3231
Cheng Z, Al Zaki A, Hui JZ et al (2012) Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338:903–910
Geppert M, Hohnholt MC, Thiel K et al (2011) Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 22:145101
Geppert M, Hohnholt MC, Nürnberger S et al (2012) Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8:3832–3839
Petters C, Dringen R (2015) Uptake, metabolism and toxicity of iron oxide nanoparticles in cultured microglia, astrocytes and neurons. Springerplus 4:L32
Couto D, Sousa R, Andrade L et al (2015) Polyacrylic acid coated and non-coated iron oxide nanoparticles are not genotoxic to human T lymphocytes. Toxicol Lett 234:67–73
Xu Y, Sherwood JA, Lackey KH et al (2016) The responses of immune cells to iron oxide nanoparticles. J Appl Toxicol 36:543–553
Bigini P, Diana V, Barbera S et al (2012) Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease. PLoS One 7:e32326
Bin NH, Palui G, Rosenberg JT et al (2012) Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles. ACS Nano 6:389–399
Rosenberg JT, Sachi-Kocher A, Davidson MW et al (2012) Intracellular SPIO labeling of microglia: high field considerations and limitations for MR microscopy. Contrast Media Mol Imaging 7:121–129
Jarockyte G, Daugelaite E, Stasys M et al (2016) Accumulation and toxicity of superparamagnetic iron oxide nanoparticles in cells and experimental animals. Int J Mol Sci 17:1193
Rojas JM, Sanz-Ortega L, Mulens-Arias V et al (2016) Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion. Nanomedicine Nanotechnol Biol Med 12:1127–1138
Szalay B, Tátrai E, Nyírő G et al (2012) Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J Appl Toxicol 32:446–453
Paolini A, Guarch CP, Ramos-López D et al (2016) Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity. J Appl Toxicol 36:510–520
Schaub NJ, Rende D, Yuan Y et al (2014) Reduced astrocyte viability at physiological temperatures from magnetically activated iron oxide nanoparticles. Chem Res Toxicol 27:2023–2035
Ahamed M, Akhtar MJ, Khan MAM et al (2016) Cobalt iron oxide nanoparticles induce cytotoxicity and regulate the apoptotic genes through ROS in human liver cells (HepG2). Colloids Surf B: Biointerfaces 148:665–673
Ying E, Hwang H-M (2010) In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 408:4475–4481
Costa C, Brandão F, Bessa MJ et al (2016) In vitro cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells. Evaluation of nanoparticle interference with viability tests. J Appl Toxicol 36:361–372
Nel A, Xia T, Mädler L et al (2006) Toxic potential of materials at the nanolevel. Science 311:622–627
Unfried K, Albrecht C, Klotz L-O et al (2007) Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1:52–71
Liu G, Gao J, Ai H et al (2013) Applications and potential toxicity of magnetic iron oxide nanoparticles. Small Weinh Bergstr Ger 9:1533–1545
Pisanic TR, Jin S, Shubayev VI 2009 Iron oxide magnetic nanoparticle nanotoxicity: incidence and mechanisms. In: Sahu SC, Casciano DA (eds) Nanotoxicity. Wiley, New York, pp 397–425
Hanot CC, Choi YS, Anani TB et al (2015) Effects of iron-oxide nanoparticle surface chemistry on uptake kinetics and cytotoxicity in CHO-K1 cells. Int J Mol Sci 17:E54
Naqvi S, Samim M, Abdin MZ et al (2010) Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine 5:983–989
Hanini A, Schmitt A, Kacem K et al (2011) Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomedicine 6:787–794
Zhu M-T, Wang B, Wang Y et al (2011) Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett 203:162–171
Zhang T, Qian L, Tang M et al (2012) Evaluation on cytotoxicity and genotoxicity of the L-glutamic acid coated iron oxide nanoparticles. J Nanosci Nanotechnol 12:2866–2873
Watanabe M, Yoneda M, Morohashi A et al (2013) Effects of Fe3O4 magnetic nanoparticles on A549 cells. Int J Mol Sci 14:15546–15560
Könczöl M, Ebeling S, Goldenberg E et al (2011) Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem Res Toxicol 24:1460–1475
Du S, Li J, Du C et al (2017) Overendocytosis of superparamagnetic iron oxide particles increases apoptosis and triggers autophagic cell death in human osteosarcoma cell under a spinning magnetic field. Oncotarget 8:9410–9424
Petters C, Thiel K, Dringen R (2015) Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes. Nanotoxicology 10:1743–5390
Wu J, Wang C, Sun J et al (2011) Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 5:4476–4489
Wang Y, Wang B, Zhu MT et al (2011) Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 205:26–37
Kenzaoui BH, Bernasconi CC, Hofmann H et al (2012) Evaluation of uptake and transport of ultrasmall superparamagnetic iron oxide nanoparticles by human brain-derived endothelial cells. Nanomedicine 7:39–53
Pongrac IM, Dobrivojevi M, Ahmed LB et al (2016) Improved biocompatibility and efficient labeling of neural stem cells with poly(L-lysine)-coated maghemite nanoparticles. Beilstein J Nanotechnol 7:926–936
Hildebrand H, Kühnel D, Potthoff A et al (2010) Evaluating the cytotoxicity of palladium/magnetite nano-catalysts intended for wastewater treatment. 158:65–73
Hohnholt M, Geppert M, Dringen R (2010) Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells. Neurochem Res 35:1259–1268
Hohnholt MC, Geppert M, Dringen R (2011) Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomater 7:3946–3954
Lindemann A, Fraederich BM, Pries R et al (2014) Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Int J Nanomedicine 9:5025–5040
Remya NS, Syama S, Sabareeswaran A et al (2016) Toxicity, toxicokinetics and biodistribution of dextran stabilized iron oxide nanoparticles for biomedical applications. Int J Pharm 511:586–598
Khan MI, Mohammad A, Patil G et al (2012) Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 33:1477–1488
Mukhopadhyay A, Joshi N, Chattopadhyay K et al (2012) A facile synthesis of PEG-coated magnetite (Fe 3O 4) nanoparticles and their prevention of the reduction of cytochrome C. ACS Appl Mater Interfaces 4:142–149
Sarkar A, Ghosh M, Sil PC (2014) Nanotoxicity: oxidative stress mediated toxicity of metal and metal oxide nanoparticles. J Nanosci Nanotechnol 14:730–743
Ding FA, Li YP, Liu J et al (2014) Overendocytosis of gold nanoparticles increases autophagy and apoptosis in hypoxic human renal proximal tubular cells. Int J Nanomedicine 9:4317–4330
Baratli Y, Charles AL, Wolff V et al (2014) Age modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats. Biomed Res Int 2014:474081
Zhang X, Zhang H, Liang X et al (2016) Iron oxide nanoparticles induce autophagosome accumulation through multiple mechanisms: lysosome impairment, mitochondrial damage, and ER stress. Mol Pharm 13:2578–2587
Coccini T, Caloni F, Ramírez Cando LJ et al (2017) Cytotoxicity and proliferative capacity impairment induced on human brain cell cultures after short- and long-term exposure to magnetite nanoparticles. J Appl Toxicol 37:361–373
Lee JH, Ju JE, Kim BI et al (2014) Rod-shaped iron oxide nanoparticles are more toxic than sphere-shaped nanoparticles to murine macrophage cells. Environ Toxicol Chem 33:2759–2766
Dönmez Güngüneş Ç, Şeker Ş, Elçin AE et al (2017) A comparative study on the in vitro cytotoxic responses of two mammalian cell types to fullerenes, carbon nanotubes and iron oxide nanoparticles. Drug Chem Toxicol:1–13
Kiliç G, Costa C, Fernández-Bertólez N et al (2016) In vitro toxicity evaluation of silica-coated iron oxide nanoparticles in human SHSY5Y neuronal cells. Toxicol Res 5:235–247
Berry CC, Wells S, Charles S et al (2003) Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24:4551–4557
Li L, Mak KY, Shi J et al (2012) Comparative in vitro cytotoxicity study on uncoated magnetic nanoparticles: effects on cell viability, cell morphology, and cellular uptake. J Nanosci Nanotechnol 12:9010–9017
Bhattacharya K, Davoren M, Boertz J et al (2009) Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol 6:17
Singh N, Jenkins GJS, Nelson BC et al (2012) The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 33:163–170
Guichard Y, Schmit J, Darne C et al (2012) Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells. Ann Occup Hyg 56:631–644
Rajiv S, Jerobin J, Saranya V et al (2016) Comparative cytotoxicity and genotoxicity of cobalt (II, III) oxide, iron (III) oxide, silicon dioxide, and aluminum oxide nanoparticles on human lymphocytes in vitro. Hum Exp Toxicol 35:170–183
Cicha I, Scheffler L, Ebenau A et al (2016) Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: uptake and toxicity in primary human tubular epithelial cells. Nanotoxicology 5390:1–10
Valdiglesias V, Laffon B, Pásaro E et al (2011) Evaluation of okadaic acid-induced genotoxicity in human cells using the micronucleus test and γH2AX analysis. J Toxicol Environ Health A 74(15–16):980–992
Wu J, Sun J (2011) Investigation on mechanism of growth arrest induced by iron oxide nanoparticles in PC12 cells. J Nanosci Nanotechnol 11:11079–11083
Augustin E, Czubek B, Nowicka AM et al (2016) Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles. Toxicol In Vitro 33:45–53
Periasamy VS, Athinarayanan J, Alhazmi M et al (2016) Fe 3 O 4 nanoparticle redox system modulation via cell-cycle progression and gene expression in human mesenchymal stem cells. Environ Toxicol 31:901–912
Lai X, Wei Y, Zhao H et al (2015) The effect of Fe 2 O 3 and ZnO nanoparticles on cytotoxicity and glucose metabolism in lung epithelial cells. J Appl Toxicol 35:651–664
Berry CC, Wells S, Charles S et al (2004) Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25:5405–5413
Kim JH, Sanetuntikul J, Shanmugam S et al (2015) Necrotic cell death caused by exposure to graphitic carbon-coated magnetic nanoparticles. J Biomed Mater Res – Part A 103:2875–2887
Shi M, Cheng L, Zhang Z et al (2015) Ferroferric oxide nanoparticles induce prosurvival autophagy in human blood cells by modulating the Beclin 1/Bcl-2/VPs34 complex. Int J Nanomedicine 10:207–216
Park EJ, Choi DH, Kim Y et al (2014) Magnetic iron oxide nanoparticles induce autophagy preceding apoptosis through mitochondrial damage and ER stress in RAW264.7 cells. Toxicol In Vitro 28:1402–1412
Buyukhatipoglu K, Clyne AM (2011) Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A 96:186–195
Gonnissen D, Qu Y, Langer K et al (2016) Comparison of cellular effects of starch-coated SPIONs and poly(lactic-co-glycolic acid) matrix nanoparticles on human monocytes. Int J Nanomedicine 11:5221–5236
Kalive M, Zhang W, Chen Y et al (2012) Human intestinal epithelial cells exhibit a cellular response indicating a potential toxicity upon exposure to hematite nanoparticles. Cell Biol Toxicol 28:343–368
Kedziorek DA, Muja N, Walczak P et al (2010) Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med 63:1031–1043
Alarifi S, Ali D, Alkahtani S et al (2013) Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles. Int J Nanomedicine 8:983–993
Liu Y, Wang J (2013) Effects of DMSA-Coated Fe3O4 nanoparticles on the transcription of genes related to iron and osmosis homeostasis. Toxicol Sci 131:521–536
Könczöl M, Weiss A, Stangenberg E et al (2013) Cell-cycle changes and oxidative stress response to magnetite in A549 human lung cells. Chem Res Toxicol 26:693–702
Shubayev VI, Pisanic TR, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61:467–477
Soenen SJH, De Cuyper M (2009) Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging 4:207–219
Stroh A, Zimmer C, Gutzeit C et al (2004) Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 36:976–984
Shander A, Cappellini MD, Goodnough LT (2009) Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang 97:185–197
Geppert M, Hohnholt M, Gaetjen L et al (2009) Accumulation of iron oxide nanoparticles by cultured brain astrocytes. J Biomed Nanotechnol 5:285–293
Toyokuni S (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20:553–566
Valko M, Rhodes CJ, Moncol J et al (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40
Acknowledgements
This work was supported by Xunta de Galicia (grant number ED431B 2016/013) and the projects NanoToxClass (ERA-SIINN/001/2013) funded by FCT/MCTES (PIDDAC) and co-funded by the European Regional Development Fund (ERDF) through the COMPETE Programme, and CERASAFE (SIINN/0004/2014) funded by FCT (national funds of MES) and co-funded by the European Union (ERA-NET SIINN programme). V. Valdiglesias was supported by a Xunta de Galicia postdoctoral fellowship (reference ED481B 2016/190-0). N. Fernández-Bertólez was supported by an INDITEX-UDC fellowship. F. Brandão was supported by the grant SFRH/BD/101060/2014, funded by FCT (financing subsided by national fund of MES).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
Laffon, B. et al. (2018). Cellular and Molecular Toxicity of Iron Oxide Nanoparticles. In: Saquib, Q., Faisal, M., Al-Khedhairy, A., Alatar, A. (eds) Cellular and Molecular Toxicology of Nanoparticles. Advances in Experimental Medicine and Biology, vol 1048. Springer, Cham. https://doi.org/10.1007/978-3-319-72041-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-72041-8_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72040-1
Online ISBN: 978-3-319-72041-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)